Rein Therapeutics Inc. (RNTX)

Rein Therapeutics Statistics

Total Valuation

RNTX has a market cap or net worth of $99.55 million. The enterprise value is $100.03 million.

Market Cap	99.55M
Enterprise Value	100.03M

Important Dates

The last earnings date was Friday, May 15, 2026, before market open.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

RNTX has 93.04 million shares outstanding. The number of shares has increased by 29.11% in one year.

Current Share Class	93.04M
Shares Outstanding	93.04M
Shares Change (YoY)	+29.11%
Shares Change (QoQ)	+3.72%
Owned by Insiders (%)	5.91%
Owned by Institutions (%)	13.74%
Float	78.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40, with a Debt / Equity ratio of 0.42.

Current Ratio	0.40
Quick Ratio	0.33
Debt / Equity	0.42
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -163.36% and return on invested capital (ROIC) is -40.58%.

Return on Equity (ROE)	-163.36%
Return on Assets (ROA)	-32.10%
Return on Invested Capital (ROIC)	-40.58%
Return on Capital Employed (ROCE)	-170.36%
Weighted Average Cost of Capital (WACC)	11.48%
Revenue Per Employee	n/a
Profits Per Employee	-$5.02M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-712,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.80% in the last 52 weeks. The beta is 1.42, so RNTX's price volatility has been higher than the market average.

Beta (5Y)	1.42
52-Week Price Change	-47.80%
50-Day Moving Average	1.34
200-Day Moving Average	1.30
Relative Strength Index (RSI)	41.52
Average Volume (20 Days)	1,527,573

Short Selling Information

The latest short interest is 835,368, so 0.90% of the outstanding shares have been sold short.

Short Interest	835,368
Short Previous Month	236,711
Short % of Shares Out	0.90%
Short % of Float	1.07%
Short Ratio (days to cover)	4.54

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.55M
Pretax Income	-50.92M
Net Income	-50.21M
EBITDA	-21.57M
EBIT	-21.55M
Earnings Per Share (EPS)	-$1.82

Balance Sheet

The company has $4.45 million in cash and $4.92 million in debt, with a net cash position of -$478,000 or -$0.01 per share.

Cash & Cash Equivalents	4.45M
Total Debt	4.92M
Net Cash	-478,000
Net Cash Per Share	-$0.01
Equity (Book Value)	11.59M
Book Value Per Share	-1.19
Working Capital	-8.18M

Cash Flow

Operating Cash Flow	-16.61M
Capital Expenditures	n/a
Depreciation & Amortization	-14,500
Net Borrowing	4.30M
Free Cash Flow	-16.61M
FCF Per Share	-$0.18

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.11%
Shareholder Yield	-29.11%
Earnings Yield	-50.43%
FCF Yield	-16.68%

Analyst Forecast

The average price target for RNTX is $10.00, which is 834.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	834.58%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 11, 2022. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 11, 2022
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1